2,3 Against this backdrop, oral GLP-1 receptor agonists are emerging as an increasingly important area of focus, as companies look to extend growth beyond injectables and broaden access to obesity care
Products are not intended for the preparation, reconstitution, dilution, combination, or transfer of any substance for administration to humans or animals, and are not intended to be used in conjunction with any other products for such purposes
However, the interpretation of these findings requires careful consideration of methodological challenges including confounding variables, exposure misclassification, and the inherent complexity of dose-response relationships
Take charge of your journey today and experience the benefits of a program with your success in mind
Nevertheless, the observed within-patient improvements after escalation remain clinically informative and support the clinical relevance of dose escalation to 1.0 mg when treatment goals are not achieved on 0.5 mg